Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapy

The content for this activity is based on the satellite symposium, “Current Strategies for the Long-term Assessment, Monitoring, and Management for Cystic Fibrosis Patients Treated with CFTR Modulator Therapy” that was presented at the 39th European Cystic Fibrosis Society Conference on June 10, 201...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Elborn, J. Stuart (VerfasserIn) , Mall, Marcus A. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January 2017
In: Journal of cystic fibrosis
Year: 2017, Jahrgang: 16, Heft: 1, Pages: 163-164
ISSN:1873-5010
DOI:10.1016/j.jcf.2016.11.009
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.jcf.2016.11.009
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1569199316306671
Volltext
Verfasserangaben:J. Stuart Elborn, Jane Davies, Marcus A. Mall, Patrick A. Flume, Barry Plant

MARC

LEADER 00000caa a2200000 c 4500
001 1584518316
003 DE-627
005 20230427161330.0
007 cr uuu---uuuuu
008 181127s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jcf.2016.11.009  |2 doi 
035 |a (DE-627)1584518316 
035 |a (DE-576)514518316 
035 |a (DE-599)BSZ514518316 
035 |a (OCoLC)1341024485 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Elborn, J. Stuart  |e VerfasserIn  |0 (DE-588)1172322015  |0 (DE-627)1041134916  |0 (DE-576)514520612  |4 aut 
245 1 0 |a Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapy  |c J. Stuart Elborn, Jane Davies, Marcus A. Mall, Patrick A. Flume, Barry Plant 
264 1 |c January 2017 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.11.2018 
520 |a The content for this activity is based on the satellite symposium, “Current Strategies for the Long-term Assessment, Monitoring, and Management for Cystic Fibrosis Patients Treated with CFTR Modulator Therapy” that was presented at the 39th European Cystic Fibrosis Society Conference on June 10, 2016 (Online access: http://courses.elseviercme.com/ecfs2016e/619e). The emergence of novel targeted agents, that directly correct CFTR loss function alleles, has created new treatment opportunities for patients with cystic fibrosis with advanced disease. Knowledge of the role of these agents in the clinical setting is quickly evolving and will require physicians to stay acquainted with the latest data as well as evidence-based treatment guidelines in order to achieve optimized cystic fibrosis patient care. Ideally, after diagnosis, a personalized approach would be adapted and tailored to the patient through genome-informed medicine. However, due to the relative recentness of genomic-based therapeutics, physicians may have a limited knowledge base regarding these new treatment options and how to best incorporate these agents into patient management plans. Although cystic fibrosis is still largely regarded as a pediatric disease, the median survival for patients is 35years of age. Consequently, pediatric-to-adult cystic fibrosis care programs would allow suitable preparation time for this transition and develop a standardized group of self-care and management skills. 
700 1 |a Mall, Marcus A.  |d 1975-  |e VerfasserIn  |0 (DE-588)115507795  |0 (DE-627)691370532  |0 (DE-576)28992152X  |4 aut 
773 0 8 |i Enthalten in  |t Journal of cystic fibrosis  |d Amsterdam [u.a.] : Elsevier Science, 2002  |g 16(2017), 1, Seite 163-164  |h Online-Ressource  |w (DE-627)35598539X  |w (DE-600)2091075-7  |w (DE-576)271360909  |x 1873-5010  |7 nnas  |a Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapy 
773 1 8 |g volume:16  |g year:2017  |g number:1  |g pages:163-164  |g extent:2  |a Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapy 
856 4 0 |u http://dx.doi.org/10.1016/j.jcf.2016.11.009  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1569199316306671  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181127 
993 |a Article 
994 |a 2017 
998 |g 115507795  |a Mall, Marcus A.  |m 115507795:Mall, Marcus A.  |d 910000  |d 910500  |e 910000PM115507795  |e 910500PM115507795  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1584518316  |e 3034191499 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapy","title_sort":"Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapy"}],"person":[{"family":"Elborn","given":"J. Stuart","display":"Elborn, J. Stuart","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Marcus A.","family":"Mall","role":"aut","roleDisplay":"VerfasserIn","display":"Mall, Marcus A."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 27.11.2018"],"language":["eng"],"recId":"1584518316","origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"January 2017"}],"id":{"doi":["10.1016/j.jcf.2016.11.009"],"eki":["1584518316"]},"name":{"displayForm":["J. Stuart Elborn, Jane Davies, Marcus A. Mall, Patrick A. Flume, Barry Plant"]},"physDesc":[{"extent":"2 S."}],"relHost":[{"origin":[{"dateIssuedDisp":"2002-","dateIssuedKey":"2002","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]"}],"id":{"issn":["1873-5010"],"zdb":["2091075-7"],"eki":["35598539X"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of cystic fibrosis","subtitle":"the official journal of the European Cystic Fibrosis Society","title":"Journal of cystic fibrosis"}],"disp":"Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapyJournal of cystic fibrosis","note":["Gesehen am 10.02.2016"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"35598539X","language":["eng"],"pubHistory":["1.2002 -"],"part":{"year":"2017","pages":"163-164","issue":"1","text":"16(2017), 1, Seite 163-164","volume":"16","extent":"2"},"titleAlt":[{"title":"Cystic fibrosis"}]}]} 
SRT |a ELBORNJSTUCURRENTSTR2017